Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00318292 · ClinicalTrials.gov registry record · Phase 4

Preemptive Local Anesthesia in Vaginal Surgery

A Phase 4 study of Pain, Postoperative, sponsored by Mayo Clinic.

Completed
Registry status
Phase 4
Development phase
90
Enrollment target
1
Study location

NCT00318292: Completed Phase 4 study of Pain, Postoperative, sponsored by Mayo Clinic.

NCT00318292 is a Phase 4 study of Pain, Postoperative that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00318292, a Phase 4 study of Pain, Postoperative, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Phase 4
Development phase
90 participants
Enrollment target
1
Study location

Study Summary

Preemptive analgesia is an intervention which provides an anesthetic prior to initiating a painful stimulus. This trial is examining the effects of a local anesthetic given at the point of innervation prior to performing a vaginal hysterectomy with suspension sutures.

Primary Outcome

Visual Analogue Scale (VAS) pain score on a scale from 0 (None) to 10 (Worst) points.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG bupivacaine and epinephrine

Study Locations (1)

Arizona

  • Mayo Clinic - Scottsdale

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2006-04
Est. Completion 2008-03
Phase Phase 4
Mayo Clinic

2,844 total trials

What the finished NCT00318292 record still lists

NCT00318292 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 272-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00318292 reports a single indexed study location in Arizona.

Frequently Asked Questions

What is clinical trial NCT00318292 about?

NCT00318292 is a clinical study titled "Preemptive Local Anesthesia in Vaginal Surgery". Preemptive analgesia is an intervention which provides an anesthetic prior to initiating a painful stimulus. This trial is examining the effects of a local anesthetic given at the point of innervation prior to performing a vaginal hysterectomy with suspension sutures.

What is the current status of trial NCT00318292?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2006-04. Estimated completion is 2008-03.

What conditions does trial NCT00318292 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT00318292?

The interventions under investigation include: Placebo (DRUG), bupivacaine and epinephrine (DRUG).

Who is sponsoring clinical trial NCT00318292?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00318292 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00318292's enrollment target sits among peer trials

90 50th of 113 higher than 61 of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02521311 · 90 participants · Phase 2

    Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

  • NCT02939573 · 90 participants · Phase 2

    A Randomized Multicenter Study for Isolated Skin Vasculitis

  • NCT03128879 · 90 participants · Phase 2

    Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL

  • NCT03184038 · 90 participants · NA

    Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00318292, the US trial registry maintained by the National Library of Medicine. NCT00318292 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.